These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7751527)

  • 21. A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold.
    Dockhorn R; Grossman J; Posner M; Zinny M; Tinkleman D
    J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1076-82. PubMed ID: 1460211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anticholinergic treatment of allergic perennial rhinitis.
    Georgitis JW
    J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1071-6. PubMed ID: 1460210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cold air-induced rhinorrhea and high-dose ipratropium.
    Ostberg B; Winther B; Mygind N
    Arch Otolaryngol Head Neck Surg; 1987 Feb; 113(2):160-2. PubMed ID: 2948526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study.
    Sjögren I; Jonsson L; Köling A; Jansson C; Osterman K; Håkansson B
    Acta Otolaryngol; 1988; 106(5-6):453-9. PubMed ID: 2974675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ipratropium in the treatment of patients with perennial rhinitis.
    Sjögren I; Juhász J
    Allergy; 1984 Aug; 39(6):457-61. PubMed ID: 6238545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide.
    Dolovich J; Kennedy L; Vickerson F; Kazim F
    J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):274-8. PubMed ID: 2957416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ipratropium treatment for rhinorrhoea in patients with perennial rhinitis. An open follow-up study of efficacy and safety.
    Schultz Larsen F; Mygind N; Larsen FS
    Clin Otolaryngol Allied Sci; 1983 Aug; 8(4):267-72. PubMed ID: 6228346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of gustatory rhinorrhoea by intranasal ipratropium bromide.
    Choudry NB; Harrison AJ; Fuller RW
    Eur J Clin Pharmacol; 1992; 42(5):561-2. PubMed ID: 1535047
    [No Abstract]   [Full Text] [Related]  

  • 29. Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion.
    Ostberg B; Winther B; Borum P; Mygind N
    Rhinology; 1997 Jun; 35(2):58-62. PubMed ID: 9299652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis.
    Druce HM; Spector SL; Fireman P; Kaiser H; Meltzer EO; Boggs P; Wood CC; Paluch EP
    Ann Allergy; 1992 Jul; 69(1):53-60. PubMed ID: 1385682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ipratropium bromide on bradykinin nasal provocation in chronic allergic rhinitis.
    Baraniuk JN; Silver PB; Kaliner MA; Barnes PJ
    Clin Exp Allergy; 1994 Aug; 24(8):724-9. PubMed ID: 7982121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children.
    Milgrom H; Biondi R; Georgitis JW; Meltzer EO; Munk ZM; Drda K; Wood CC
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):105-11. PubMed ID: 10480582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasal mucosal inflammation has no effect on the absorption of intranasal triamcinolone acetonide.
    Argenti D; Colligon I; Heald D; Ziemniak J
    J Clin Pharmacol; 1994 Aug; 34(8):854-8. PubMed ID: 7962675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of action of intranasal atropine on methacholine-induced nasal secretions.
    Baroody FM; Driscoll PV; Moylan B; Fleming L; Shilstone J; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):321-3. PubMed ID: 8607961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide.
    Naclerio RM; Baroody FM
    J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1051-4. PubMed ID: 1460207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nasal methacholine provocation and ipratropium therapy of perennial rhinitis.
    Borum P; Larsen FS; Mygind N
    Acta Otolaryngol Suppl; 1979; 360():35-9. PubMed ID: 156486
    [No Abstract]   [Full Text] [Related]  

  • 37. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold.
    Borum P; Olsen L; Winther B; Mygind N
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):418-20. PubMed ID: 6452842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a cholino-ceptor antagonist in the nose.
    Mygind N; Borum P
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():167-74. PubMed ID: 6225664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ipratropium bromide increases the ability of the nose to warm and humidify air.
    Assanasen P; Baroody FM; Rouadi P; Naureckas E; Solway J; Naclerio RM
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):1031-7. PubMed ID: 10988126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ipratropium bromide treatment of experimental rhinovirus infection.
    Gaffey MJ; Hayden FG; Boyd JC; Gwaltney JM
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1644-7. PubMed ID: 2855297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.